Search results
Biotech Stock Roundup: ICPT Up on Buyout Deal, IMVT & PLRX Gain on Study Data
Zacks via Yahoo Finance· 8 months agoIt was a busy week for the biotech sector, with a lot of important regulatory and pipeline updates....
Intercept (ICPT) Announces Delay in Meeting With the FDA
Zacks via Yahoo Finance· 2 years agoIntercept Pharmaceuticals, Inc. ICPT has announced a delay in its pre-submission meeting with the...
Intercept Pharmaceuticals Crashes After Drug Fails In Cirrhotic Patients
Investor's Business Daily· 2 years agoIntercept Pharmaceuticals' experimental NASH treatment failed in patients with liver cirrhosis,...
Former Wall Street Darling Intercept Restructures After FDA Rejects Its Liver Drug
Investor's Business Daily· 11 months agoIntercept Pharmaceuticals said Friday it will restructure itself after the Food and Drug...
Biotech Stock Roundup: IRWD Announces Buyout, ICPT, SRPT & PTCT Fall on Updates
Zacks via Yahoo Finance· 1 year agoThe biotech sector has been in focus in the past week with key pipeline and regulatory updates....
Intercept Tumbles As Its Experimental NASH Drug Faces Yet Another Obstacle
Investor's Business Daily· 1 year agoIntercept Pharmaceuticals said Friday its experimental liver disease treatment will face a Food and...
Nike's Down, but These 2 Nasdaq Stocks Fell Even Further Friday
Motley Fool· 2 years agoFutures on the Nasdaq Composite (NASDAQINDEX: ^IXIC) were all over the map in premarket trading...
Stocks to Sell: 7 Overbought Companies You Ought to Dump Right Now
InvestorPlace via Yahoo Finance· 7 months agoIn rough markets it’s important to keep and eye out for overbought stocks. Finding the right timing...
10 Most Shorted Stocks to Watch in July
Insider Monkey via Yahoo Finance· 2 years agoIn this article, we discuss the 10 most shorted stocks to watch in July. If you want to skip our analysis of the US stock market, go directly to the 5...
Chemomab (CMMB) Mid-Stage Study for NASH Meets Primary Goal
Zacks via Yahoo Finance· 1 year agoChemomab Therapeutics, Ltd. CMMB announced that its mid-stage study evaluating CM-101 in...
